Ascendis Pharma A/S (ASND)
135.13
-2.32
(-1.69%)
USD |
NASDAQ |
May 31, 16:00
135.13
0.00 (0.00%)
After-Hours: 20:00
Ascendis Pharma Cash from Investing (Quarterly): 7.772M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.772M |
| December 31, 2023 | 5.472M |
| September 30, 2023 | 23.77M |
| June 30, 2023 | 54.66M |
| March 31, 2023 | 226.24M |
| December 31, 2022 | 2.112M |
| September 30, 2022 | 11.40M |
| June 30, 2022 | 8.338M |
| March 31, 2022 | 43.25M |
| December 31, 2021 | -132.42M |
| September 30, 2021 | 24.58M |
| June 30, 2021 | 13.29M |
| March 31, 2021 | -36.29M |
| December 31, 2020 | -75.21M |
| September 30, 2020 | 11.91M |
| June 30, 2020 | -262.48M |
| March 31, 2020 | -6.777M |
| December 31, 2019 | -1.294M |
| September 30, 2019 | -1.358M |
| June 30, 2019 | -0.3184M |
| March 31, 2019 | -2.805M |
| Date | Value |
|---|---|
| December 31, 2018 | -1.282M |
| September 30, 2018 | -1.324M |
| June 30, 2018 | -0.3965M |
| March 31, 2018 | -0.1253M |
| December 31, 2017 | -0.2357M |
| September 30, 2017 | -0.1863M |
| June 30, 2017 | -0.242M |
| March 31, 2017 | -0.4016M |
| December 31, 2016 | -0.1076M |
| September 30, 2016 | -0.173M |
| June 30, 2016 | -0.311M |
| March 31, 2016 | -0.1522M |
| December 31, 2015 | -0.4017M |
| September 30, 2015 | -0.0971M |
| June 30, 2015 | -0.5572M |
| March 31, 2015 | -0.097M |
| December 31, 2014 | -0.0535M |
| September 30, 2014 | -0.0681M |
| June 30, 2014 | -0.2457M |
| March 31, 2014 | -0.1713M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-262.48M
Minimum
Jun 2020
226.24M
Maximum
Mar 2023
-4.168M
Average
6.622M
Median
Cash from Investing (Quarterly) Benchmarks
| Evaxion Biotech AS | -- |
| Biodexa Pharmaceuticals Plc | -- |
| Trinity Biotech PLC | -13.96M |
| NuCana PLC | 0.0545M |
| TC BioPharm (Holdings) PLC | -0.0071M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -110.34M |
| Cash from Financing (Quarterly) | 20.01M |
| Free Cash Flow | -460.07M |
| Free Cash Flow Per Share (Quarterly) | -1.944 |
| Free Cash Flow to Equity (Quarterly) | -230.06M |
| Free Cash Flow to Firm (Quarterly) | -29.07M |
| Free Cash Flow Yield | -6.03% |